$ARQT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Arcutis Biotherapeutics, Inc.. Get notifications about new insider transactions in Arcutis Biotherapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 27.50 | 6,755 | 185,763 | 841,391 | 848.1 K to 841.4 K (-0.80 %) |
Jun 28 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 27.50 | 729 | 20,048 | 848,146 | 848.9 K to 848.1 K (-0.09 %) |
Jun 16 2021 | ARQT | Arcutis Biotherape ... | LIN SUE-JEAN | Director | Option Exercise | A | 27.77 | 25,723 | 714,328 | 25,723 | |
Jun 11 2021 | ARQT | Arcutis Biotherape ... | Sun Ricky | Director | Option Exercise | A | 27.77 | 13,391 | 371,868 | 13,391 | |
Jun 11 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Option Exercise | A | 27.77 | 13,391 | 371,868 | 13,391 | |
May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | J | 0.00 | 96,574 | 0 | 0 | 96.6 K to 0 (-100.00 %) |
May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | J | 0.00 | 96,574 | 0 | 96,574 | 0 to 96.6 K |
May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | J | 0.00 | 2,108,558 | 0 | 8,434,232 | 10.5 M to 8.4 M (-20.00 %) |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 750 | 1,260 | 133,135 | |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.00 | 750 | 26,250 | 593,773 | 594.5 K to 593.8 K (-0.13 %) |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 750 | 1,260 | 594,523 | 593.8 K to 594.5 K (+0.13 %) |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 1,607 | 2,701 | 133,885 | |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 34.00 | 1,750 | 59,500 | 593,773 | 595.5 K to 593.8 K (-0.29 %) |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 1,607 | 2,701 | 595,523 | 593.9 K to 595.5 K (+0.27 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 6.52 | 1,028 | 6,705 | 11,919 | |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 781 | 1,313 | 24,990 | |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 11,714 | |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 35.12 | 917 | 32,209 | 210,941 | 211.9 K to 210.9 K (-0.43 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 34.56 | 1,283 | 44,339 | 211,858 | 213.1 K to 211.9 K (-0.60 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 6.52 | 1,028 | 6,705 | 213,141 | 212.1 K to 213.1 K (+0.48 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 781 | 1,313 | 212,113 | 211.3 K to 212.1 K (+0.37 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 211,332 | 210.9 K to 211.3 K (+0.19 %) |
May 04 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.00 | 1,500 | 52,500 | 593,916 | 595.4 K to 593.9 K (-0.25 %) |
Apr 22 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 28.53 | 1,280 | 36,515 | 861,391 | 862.7 K to 861.4 K (-0.15 %) |
Apr 22 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 27.99 | 8,720 | 244,053 | 862,671 | 871.4 K to 862.7 K (-1.00 %) |
Apr 20 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 20,774 | |
Apr 20 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,042 | 1,751 | 23,949 | |
Apr 20 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 10,543 | |
Apr 20 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 210,941 | 209.7 K to 210.9 K (+0.58 %) |
Apr 20 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,042 | 1,751 | 209,719 | 208.7 K to 209.7 K (+0.50 %) |
Apr 20 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 208,677 | 208.3 K to 208.7 K (+0.19 %) |
Apr 06 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 29.93 | 1,750 | 52,378 | 595,416 | 597.2 K to 595.4 K (-0.29 %) |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Burrows Scott L | Chief Financial Off ... | Option Exercise | A | 29.74 | 23,000 | 684,020 | 23,000 | |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 6.52 | 1,029 | 6,711 | 12,947 | |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 781 | 1,313 | 25,771 | |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 390 | 655 | 12,105 | |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 29.75 | 1,040 | 30,945 | 208,286 | 209.3 K to 208.3 K (-0.50 %) |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 29.25 | 1,160 | 33,935 | 209,326 | 210.5 K to 209.3 K (-0.55 %) |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 6.52 | 1,029 | 6,711 | 210,486 | 209.5 K to 210.5 K (+0.49 %) |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 781 | 1,313 | 209,457 | 208.7 K to 209.5 K (+0.37 %) |
Apr 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 390 | 655 | 208,676 | 208.3 K to 208.7 K (+0.19 %) |
Mar 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 31.43 | 4,992 | 156,906 | 871,391 | 876.4 K to 871.4 K (-0.57 %) |
Mar 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 30.77 | 5,008 | 154,115 | 876,383 | 881.4 K to 876.4 K (-0.57 %) |
Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 21,996 | |
Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,041 | 1,750 | 24,991 | |
Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 390 | 655 | 10,934 | |
Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 208,286 | 207.1 K to 208.3 K (+0.59 %) |
Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,041 | 1,750 | 207,064 | 206 K to 207.1 K (+0.51 %) |
Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 390 | 655 | 206,023 | 205.6 K to 206 K (+0.19 %) |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 44,982 | |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 1,250 | 41,125 | 86,715 | 88 K to 86.7 K (-1.42 %) |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 500 | 16,450 | 46,321 | 46.8 K to 46.3 K (-1.07 %) |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 46,821 | 46.3 K to 46.8 K (+1.08 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | A | 32.44 | 99,200 | 3,218,048 | 99,200 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.55 | 1,750 | 53,463 | 597,166 | 598.9 K to 597.2 K (-0.29 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Grant | A | 0.00 | 32,700 | 0 | 598,916 | 566.2 K to 598.9 K (+5.78 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 12,396 | 20,833 | 97,684 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 12,396 | 20,833 | 46,321 | 33.9 K to 46.3 K (+36.54 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,500 | 0 | 33,925 | 24.4 K to 33.9 K (+38.89 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Burnett Patrick | See Remarks | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Burnett Patrick | See Remarks | Grant | A | 0.00 | 9,500 | 0 | 9,500 | 0 to 9.5 K |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Grant | A | 0.00 | 9,500 | 0 | 31,667 | 22.2 K to 31.7 K (+42.86 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Grant | A | 0.00 | 9,500 | 0 | 246,753 | 237.3 K to 246.8 K (+4.00 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Grant | A | 0.00 | 9,500 | 0 | 18,771 | 9.3 K to 18.8 K (+102.47 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.19 | 2,107 | 74,136 | 566,216 | 568.3 K to 566.2 K (-0.37 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.19 | 2,107 | 74,136 | 566,216 | 568.3 K to 566.2 K (-0.37 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Sell | S | 34.52 | 934 | 32,242 | 9,271 | 10.2 K to 9.3 K (-9.15 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Sell | S | 34.20 | 933 | 31,908 | 22,167 | 23.1 K to 22.2 K (-4.04 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Sell | S | 34.52 | 934 | 32,242 | 9,271 | 10.2 K to 9.3 K (-9.15 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Sell | S | 34.20 | 933 | 31,908 | 22,167 | 23.1 K to 22.2 K (-4.04 %) |
Feb 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 35.97 | 2,789 | 100,325 | 881,391 | 884.2 K to 881.4 K (-0.32 %) |
Feb 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 35.34 | 7,211 | 254,866 | 884,180 | 891.4 K to 884.2 K (-0.81 %) |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 23,218 | |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,041 | 1,750 | 26,032 | |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 11,324 | |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 205,633 | 204.4 K to 205.6 K (+0.60 %) |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,041 | 1,750 | 204,411 | 203.4 K to 204.4 K (+0.51 %) |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 203,370 | 203 K to 203.4 K (+0.19 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 750 | 1,260 | 45,482 | |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 2,000 | 71,280 | 87,965 | 90 K to 88 K (-2.22 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 750 | 26,730 | 25,198 | 25.9 K to 25.2 K (-2.89 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 750 | 1,260 | 25,948 | 25.2 K to 25.9 K (+2.98 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 10,000 | 16,806 | 135,492 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 34.61 | 6,700 | 231,898 | 568,323 | 575 K to 568.3 K (-1.17 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 33.64 | 3,300 | 111,017 | 575,023 | 578.3 K to 575 K (-0.57 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 10,000 | 16,806 | 578,323 | 568.3 K to 578.3 K (+1.76 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 17,909 | 30,098 | 27,073 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,952 | 3,281 | 11,715 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 17,909 | 30,098 | 202,979 | 185.1 K to 203 K (+9.68 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,952 | 3,281 | 185,070 | 183.1 K to 185.1 K (+1.07 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,820 | 3,059 | 27,333 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 380 | 639 | 12,896 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 36.00 | 50 | 1,800 | 183,118 | 183.2 K to 183.1 K (-0.03 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 35.02 | 350 | 12,259 | 183,168 | 183.5 K to 183.2 K (-0.19 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 34.49 | 1,250 | 43,114 | 183,518 | 184.8 K to 183.5 K (-0.68 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 33.45 | 550 | 18,400 | 184,768 | 185.3 K to 184.8 K (-0.30 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,820 | 3,059 | 185,318 | 183.5 K to 185.3 K (+0.99 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 380 | 639 | 183,498 | 183.1 K to 183.5 K (+0.21 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,250 | 2,101 | 46,232 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 3,750 | 131,250 | 89,965 | 93.7 K to 90 K (-4.00 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 1,250 | 43,750 | 25,198 | 26.4 K to 25.2 K (-4.73 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,250 | 2,101 | 26,448 | 25.2 K to 26.4 K (+4.96 %) |
Feb 02 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 33.25 | 9,949 | 330,804 | 891,391 | 901.3 K to 891.4 K (-1.10 %) |
Feb 02 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 27.50 | 51 | 1,403 | 901,340 | 901.4 K to 901.3 K (-0.01 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Moore Matthew Richard | SVP and Chief Busin ... | Option Exercise | A | 28.72 | 80,000 | 2,297,600 | 80,000 | |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Moore Matthew Richard | SVP and Chief Busin ... | Option Exercise | A | 28.72 | 80,000 | 2,297,600 | 80,000 | |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
Jan 14 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 24,440 | |
Jan 14 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 183,118 | 181.9 K to 183.1 K (+0.67 %) |
Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 3,000 | 5,042 | 155,492 | |
Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.00 | 3,000 | 90,000 | 566,928 | 569.9 K to 566.9 K (-0.53 %) |
Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 3,000 | 5,042 | 569,928 | 566.9 K to 569.9 K (+0.53 %) |
Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,809 | 3,040 | 29,153 | |
Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 13,276 | |
Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 27.82 | 2,200 | 61,215 | 181,896 | 184.1 K to 181.9 K (-1.20 %) |
Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,809 | 3,040 | 184,096 | 182.3 K to 184.1 K (+0.99 %) |
Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 182,287 | 181.9 K to 182.3 K (+0.21 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Sell | S | 30.00 | 15,000 | 450,000 | 250,533 | 265.5 K to 250.5 K (-5.65 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,500 | 2,521 | 47,982 | |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 3,750 | 112,500 | 94,965 | 98.7 K to 95 K (-3.80 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,500 | 45,000 | 25,198 | 26.7 K to 25.2 K (-5.62 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,500 | 2,521 | 26,698 | 25.2 K to 26.7 K (+5.95 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 25,662 | |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 181,896 | 180.7 K to 181.9 K (+0.68 %) |
Nov 04 2020 | ARQT | Arcutis Biotherape ... | Curran Terrie | Director | Option Exercise | A | 18.72 | 37,500 | 702,000 | 37,500 | |
Nov 04 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,809 | 3,039 | 32,772 | |
Nov 04 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 14,057 | |
Nov 04 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 18.27 | 2,200 | 40,186 | 178,622 | 180.8 K to 178.6 K (-1.22 %) |
Nov 04 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,809 | 3,039 | 180,822 | 179 K to 180.8 K (+1.01 %) |
Nov 04 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 179,013 | 178.6 K to 179 K (+0.22 %) |
Oct 27 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | M | 6.52 | 2,668 | 17,395 | 147,080 | |
Oct 27 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Buy | M | 6.52 | 2,668 | 17,395 | 21,863 | 19.2 K to 21.9 K (+13.90 %) |
Oct 23 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | M | 6.52 | 2,695 | 17,571 | 149,748 | |
Oct 23 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Buy | M | 6.52 | 2,695 | 17,571 | 19,195 | 16.5 K to 19.2 K (+16.33 %) |
Oct 16 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | M | 6.52 | 7,500 | 48,900 | 152,443 | |
Oct 16 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Buy | M | 6.52 | 7,500 | 48,900 | 16,500 | 9 K to 16.5 K (+83.33 %) |
Oct 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 28,106 |